Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
388.8 INR | +2.05% |
|
+1.90% | -4.30% |
Jun. 13 | Venus Remedies Bags Tender from UNICEF for Antibiotic Ceftriaxone | MT |
May. 30 | Venus Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
Sales 2022 | 5.99B 71.68M | Sales 2023 | 5.56B 66.52M | Capitalization | 2.16B 25.92M |
---|---|---|---|---|---|
Net income 2022 | 407M 4.87M | Net income 2023 | 266M 3.19M | EV / Sales 2022 | 0.6 x |
Net cash position 2022 | 4.11M 49.17K | Net cash position 2023 | 291M 3.48M | EV / Sales 2023 | 0.34 x |
P/E ratio 2022 |
8.71
x | P/E ratio 2023 |
8.15
x | Employees | 998 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 52.78% |
1 day | +2.05% | ||
1 week | +1.90% | ||
Current month | +8.44% | ||
1 month | +2.86% | ||
3 months | +18.75% | ||
6 months | -0.36% | ||
Current year | -4.30% |
![Extreme 365](/images/extremecours_fleche.png)
![Extreme 346](/images/extremecours_fleche.png)
![Extreme 281.1](/images/extremecours_fleche.png)
![Extreme 222](/images/extremecours_fleche.png)
![Extreme 145.8](/images/extremecours_fleche.png)
![Extreme 18.8](/images/extremecours_fleche.png)
![Extreme 18.8](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Ashutosh Jain
CEO | Chief Executive Officer | 47 | 07-04-30 |
Pawan Chaudhary
CHM | Chairman | 60 | 89-09-14 |
Jitendra Singh
ADM | Chief Administrative Officer | - | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilbert Wenzel
BRD | Director/Board Member | 68 | - |
Peeyush Jain
BRD | Director/Board Member | 52 | - |
Ashutosh Jain
CEO | Chief Executive Officer | 47 | 07-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-16 | 388.8 | +2.05% | 130,884 |
24-07-15 | 381 | -1.98% | 103,618 |
24-07-12 | 388.7 | -1.67% | 189,922 |
24-07-11 | 395.3 | +3.93% | 186,415 |
24-07-10 | 380.4 | -0.31% | 76,688 |
Delayed Quote NSE India S.E., July 16, 2024 at 07:40 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+61.53% | 848B | |
+38.95% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+5.89% | 234B | |
+16.53% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- VENUSREM Stock
- VENUSREM Stock